121 related articles for article (PubMed ID: 20215910)
1. The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education.
Arepally G; Bauer KA; Bhatt DL; Merli GJ; Naccarelli GV; Carter RD; Karcher RB; Berry CA; Keaton KL; Stowell SA
Crit Pathw Cardiol; 2010 Mar; 9(1):41-8. PubMed ID: 20215910
[TBL] [Abstract][Full Text] [Related]
2. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
3. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
Peterson GM; Boom K; Jackson SL; Vial JH
Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
[TBL] [Abstract][Full Text] [Related]
4. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
5. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
6. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
[TBL] [Abstract][Full Text] [Related]
7. Compliance with antithrombotic guidelines.
Caprini JA; Hyers TM
Manag Care; 2006 Sep; 15(9):49-50, 53-60, 66. PubMed ID: 17036939
[TBL] [Abstract][Full Text] [Related]
8. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Dagres N; Estner HL; Larsen TB; Blomström-Lundqvist C;
Europace; 2014 Feb; 16(2):293-8. PubMed ID: 24478291
[TBL] [Abstract][Full Text] [Related]
9. [Antithrombotic therapy in atrial fibrillation: state of the art and perspectives].
Ricci F; Renda G; De Caterina R
G Ital Cardiol (Rome); 2013 Jan; 14(1):21-34. PubMed ID: 23258202
[TBL] [Abstract][Full Text] [Related]
10. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
Pelc-Nowicka A; Bryniarski L; Mirek-Bryniarska E; Zabojszcz M
Kardiol Pol; 2009 Dec; 67(12):1335-41. PubMed ID: 20054764
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
Dinh T; Nieuwlaat R; Tieleman RG; Büller HR; van Charante NA; Prins MH; Crijns HJ
Int J Clin Pract; 2007 Jan; 61(1):24-31. PubMed ID: 17229177
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy for the treatment of venous thromboembolism.
Nutescu EA
Am J Manag Care; 2003 Oct; 9(5 Suppl):S103-14; quiz S115-20. PubMed ID: 14620791
[TBL] [Abstract][Full Text] [Related]
13. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
[TBL] [Abstract][Full Text] [Related]
14. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen JK; Cuisset T; Kirchhof P; Marín F;
Eur Heart J; 2010 Jun; 31(11):1311-8. PubMed ID: 20447945
[TBL] [Abstract][Full Text] [Related]
17. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
O'Donnell M; Weitz JI
Am J Manag Care; 2004 Apr; 10(3 Suppl):S72-82. PubMed ID: 15152749
[TBL] [Abstract][Full Text] [Related]
18. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation.
Flaker GC; McGowan DJ; Boechler M; Fortune G; Gage B
Am Heart J; 1999 Feb; 137(2):307-12. PubMed ID: 9924165
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
20. Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.
Wittkowsky AK
Am J Manag Care; 2004 Oct; 10(10 Suppl):S297-306; discussion S312-7. PubMed ID: 15605700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
